Earlier this past year, nearly fifty researchers congregated at Yale’s West Campus to learn about some of the newest and most powerful research tools provided by the Yale Center for High Throughput Cell Biology (CHTCB).
A recent study in the New England Journal of Medicine reported that GARDASIL®, the quadrivalent human papilloma virus (HPV) vaccine, which is currently administered for cervical cancer prevention in women, is also effective in preventing anal cancer in men.
Professor Robert Pietrzak is part of a research team that was awarded the Ig Nobel prize, which honors unusual and imaginative research, for their study on the effects of voluntary inhibition of urination on cognitive processes.
A team of Yale researchers led by Lisa Suter, Assistant Professor of Medicine, investigated a method which models the population outcomes and costs of devices used for total knee replacement, a method which could potentially supplement traditional device testing.
Laurie Santos tackles the question of what makes us human by studying the minds of our closest relatives, primates, and some of her recent work demonstrates that monkeys can represent the knowledge and ignorance of others, but not their beliefs.
Since its founding in 2006, the Nutrient Network (NutNet), a project initiated by Professor Melinda Smith and her colleagues, has improved the consistency of ecosystem productivity measurement, and its findings are challenging the classical relationship between productivity and species richness.
Yale, Oncolys Biopharma, and Bristol-Myers Squibb have received the Deals of Distinction Award from the Licensing Executive Society for a licensing agreement that will enable a promising antiretroviral drug, festinavir, to be developed as a treatment.
Based on evolutionary and embryological evidence, Günter Wagner has provided new insight into the evolutionary relationships between the five-fingered hand and the bird’s wing, which contains only three digits.